Oxford Financial Group Ltd. Invests $273,000 in Horizon Therapeutics Public Limited (NASDAQ:HZNP)

Oxford Financial Group Ltd. bought a new stake in Horizon Therapeutics Public Limited (NASDAQ:HZNP – Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,500 shares of the biopharmaceutical company’s stock, valued at approximately $273,000. Other hedge funds […]

Related Keywords

,Horizon Therapeutics Public ,Xponance Inc ,Elequin Securities ,Nasdaq ,Jefferies Financial Group ,Ieq Capital ,Oxford Financial Group Ltd ,Horizon Therapeutics Public Limited ,Exchange Commission ,Vanguard Personalized Indexing Management ,Horizon Therapeutics Public Limited Company ,First Republic Investment Management Inc ,Oxford Financial Group ,Free Report ,Personalized Indexing Management ,Republic Investment Management ,Therapeutics Public Limited ,Therapeutics Public ,Get Free Report ,Therapeutics Public Limited Company ,Visit Holdingschannel ,Horizon Therapeutics Public Daily ,Nasdaq Hznp ,Hznp ,Medical ,44047t10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,